BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12231078)

  • 1. Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus.
    Weissman P
    Am J Cardiol; 2002 Sep; 90(5A):42G-50G. PubMed ID: 12231078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral agents in the management of type 2 diabetes mellitus.
    Luna B; Feinglos MN
    Am Fam Physician; 2001 May; 63(9):1747-56. PubMed ID: 11352285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Wolffenbuttel BH; van Haeften TW
    Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic therapy for type 2 diabetes mellitus.
    DeFronzo RA
    Ann Intern Med; 1999 Aug; 131(4):281-303. PubMed ID: 10454950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents.
    Rosak C
    J Diabetes Complications; 2002; 16(1):123-32. PubMed ID: 11872380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of type 2 diabetes mellitus.
    Rendell MS; Kirchain WR
    Ann Pharmacother; 2000; 34(7-8):878-95. PubMed ID: 10928401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of type 2 diabetes mellitus: pharmacologic intervention.
    McCormick M; Quinn L
    J Cardiovasc Nurs; 2002 Jan; 16(2):55-67. PubMed ID: 11800068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of type 2 diabetes.
    Hermans MP; Buysschaert M
    Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes therapy. A pathophysiologically based approach.
    Mayerson AB; Inzucchi SE
    Postgrad Med; 2002 Mar; 111(3):83-4, 87-92, 95. PubMed ID: 11912999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral antidiabetic drugs: an overview.
    Melander A
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S143-7. PubMed ID: 8894498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New directions in type 2 diabetes mellitus: an update of current oral antidiabetic therapy.
    Brown DL; Brillon D
    J Natl Med Assoc; 1999 Jul; 91(7):389-95. PubMed ID: 10643211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for reappraisal of type 2 diabetes mellitus management.
    Wyne KL
    Postgrad Med; 2003 May; Spec No():5-14. PubMed ID: 12785127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for and role of thiazolidinediones in type 2 diabetes mellitus.
    Lebovitz HE
    Am J Cardiol; 2002 Sep; 90(5A):34G-41G. PubMed ID: 12231077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constructing an algorithm for managing type 2 diabetes. Focus on role of the thiazolidinediones.
    Wyne KL; Drexler AJ; Miller JL; Bell DS; Braunstein S; Nuckolls JG
    Postgrad Med; 2003 May; Spec No():63-72. PubMed ID: 12785133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update on new oral treatment for diabetes].
    Awad J; Schindel B; Schindel Y
    Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination oral agent and insulin therapy for type 2 diabetes mellitus.
    Passaro MD; Ratner RE
    Curr Diab Rep; 2001 Oct; 1(2):106-11. PubMed ID: 12643105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.